BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24034378)

  • 1. Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions.
    Chiang HC; Anadkat MJ
    J Am Acad Dermatol; 2013 Oct; 69(4):657-8. PubMed ID: 24034378
    [No Abstract]   [Full Text] [Related]  

  • 2. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
    Requena C; Llombart B; Sanmartín O
    Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab-induced acneiform eruption and the response to isotretinoin.
    Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
    Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
    [No Abstract]   [Full Text] [Related]  

  • 4. A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition.
    Wollenberg A; Moosmann N; Klein E; Katzer K
    Exp Dermatol; 2008 Sep; 17(9):790-2. PubMed ID: 18503553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.
    Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A
    Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor.
    Shin JU; Park JH; Cho BC; Lee JH
    Dermatology; 2012; 225(2):135-40. PubMed ID: 23006507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].
    Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E
    Hautarzt; 2007 Jul; 58(7):615-8. PubMed ID: 17146641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.
    Costello CM; Hill HE; Brumfiel CM; Yang YW; Swanson DL
    J Am Acad Dermatol; 2021 Mar; 84(3):840-841. PubMed ID: 33039483
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of a child with MEK inhibitor-induced acneiform eruption with low-dose isotretinoin.
    Gupta R; Craddock MF
    Pediatr Dermatol; 2022 Jul; 39(4):646-647. PubMed ID: 35896172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaccion acneiforme noduloquistica secundaria a vemurafenib con buena respuesta a isotretinoina oralSevere acneiform eruption associated with vemurafenib with response to isotretinoin.
    Elosua-Gonzalez M; Lopez-Estebaranz JL; Garcia-Zamora E; Vela-Ganuza M; Rodrigez-Vasquez X
    Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Isotretinoin for the treatment of Aripiprazol-induced acneiform rash.
    Navarro-Triviño FJ; de Jaime Ruiz P; Porras Segovia A; Garrido Torres-Puchol V
    Dermatol Ther; 2018 Jul; 31(4):e12637. PubMed ID: 30019366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab-induced acne.
    Molinari E; De Quatrebarbes J; André T; Aractingi S
    Dermatology; 2005; 211(4):330-3. PubMed ID: 16286741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology of acneiform eruptions in patients treated with epidermal growth factor receptor inhibitors.
    Brodell LA; Hepper D; Lind A; Gru AA; Anadkat MJ
    J Cutan Pathol; 2013 Oct; 40(10):865-70. PubMed ID: 23941617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acneiform eruption as a probable paradoxical reaction to adalimumab.
    Fernández-Crehuet P; Ruiz-Villaverde R
    Int J Dermatol; 2015 Aug; 54(8):e306-8. PubMed ID: 24697221
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab-induced acne: a new case and review of published reports.
    Steels E; Peretz A; Vereecken P
    J Dermatolog Treat; 2009; 20(1):59-60. PubMed ID: 18608731
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
    Eames T; Landthaler M; Karrer S
    Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe acneiform rash.
    Yamamoto DS; Viale PH; Zhao G
    Clin J Oncol Nurs; 2004 Dec; 8(6):654-6. PubMed ID: 15637959
    [No Abstract]   [Full Text] [Related]  

  • 18. Grover's disease induced by cetuximab.
    Tscharner GG; Bühler S; Borner M; Hunziker T
    Dermatology; 2006; 213(1):37-9. PubMed ID: 16778425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with adapalene of cetuximab-induced acneiform eruptions.
    Taguchi K; Fukunaga A; Okuno T; Nishigori C
    J Dermatol; 2012 Sep; 39(9):792-4. PubMed ID: 22168666
    [No Abstract]   [Full Text] [Related]  

  • 20. Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.
    Jacot W; Bessis D; Jorda E; Ychou M; Fabbro M; Pujol JL; Guillot B
    Br J Dermatol; 2004 Jul; 151(1):238-41. PubMed ID: 15270903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.